Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Influenza

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    June 2018
  1. YOON JJ, Toots M, Lee S, Lee ME, et al
    Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00766.
    PubMed     Text format     Abstract available


    March 2018
  2. VIGIL A, Estelles A, Kauvar LM, Johnson SK, et al
    Native human monoclonal antibodies with potent cross-lineage neutralization of influenza B viruses.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.02269.
    PubMed     Text format     Abstract available


    January 2018
  3. MCBRIDE JM, Lim JJ, Burgess T, Deng R, et al
    Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat".
    Antimicrob Agents Chemother. 2017;62.
    PubMed     Text format    


  4. HUNSBERGER S, Memoli MJ
    Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat.
    Antimicrob Agents Chemother. 2017;62.
    PubMed     Text format    


    November 2017
  5. TSUJI BT, Fisher J, Boadi-Yeboah R, Holden PN, et al
    Azithromycin Pharmacodynamics against 'Persistent' Haemophilus influenza in Chronic Obstructive Pulmonary Disease.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.01995.
    PubMed     Text format     Abstract available


    August 2017
  6. MCBRIDE JM, Lim JJ, Burgess T, Deng R, et al
    Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Challenge Model: A Phase 2 Randomized Trial.
    Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.01154.
    PubMed     Text format     Abstract available


    May 2017
  7. LIM JJ, Derby MA, Zhang Y, Deng R, et al
    A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Monoclonal Antibody, MHAB5553A, in Healthy Volunteers.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00279.
    PubMed     Text format     Abstract available


    April 2017
  8. STAROSILA D, Rybalko S, Varbanetz L, Ivanskaya N, et al
    Anti-influenza activity of Bacillus subtilis probiotic strain.
    Antimicrob Agents Chemother. 2017 Apr 17. pii: AAC.00539.
    PubMed     Text format     Abstract available


  9. GAILLARD V, Galloux M, Garcin D, Eleouet JF, et al
    A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    March 2017
  10. GRIFFIN MP, Khan AA, Esser MT, Jensen K, et al
    Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    February 2017
  11. JONES JC, Marathe BM, Vogel P, Gasser R, et al
    The PA endonuclease inhibitor RO-7 protects mice from lethal challenge with influenza A or B viruses.
    Antimicrob Agents Chemother. 2017 Feb 13. pii: AAC.02460.
    PubMed     Text format     Abstract available


    August 2016
  12. VANDERLINDEN E, Vrancken B, Van Houdt J, Rajwanshi VK, et al
    Distinct effects of T-705 (favipiravir) and ribavirin on influenza virus replication and viral RNA synthesis.
    Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.01156.
    PubMed     Text format     Abstract available


    July 2016
  13. JONES JC, Marathe BM, Lerner C, Kreis L, et al
    A novel endonuclease inhibitor exhibits broad-spectrum anti-influenza activity in vitro.
    Antimicrob Agents Chemother. 2016 Jul 5. pii: AAC.00888.
    PubMed     Text format     Abstract available


  14. LIM JJ, Deng R, Derby MA, Larouche R, et al
    Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Studies to Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Monoclonal Antibody, MHAA4549A, in Healthy Volunteers.
    Antimicrob Agents Chemother. 2016 Jul 5. pii: AAC.00607.
    PubMed     Text format     Abstract available


    March 2016
  15. KAMAL MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, et al
    Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression.
    Antimicrob Agents Chemother. 2016;60:1953.
    PubMed     Text format    


    January 2016
  16. BARANOVICH T, Jones JC, Russier M, Vogel P, et al
    The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
    Antimicrob Agents Chemother. 2016 Jan 19. pii: AAC.02457.
    PubMed     Text format     Abstract available


  17. CIEJKA J, Milewska A, Wytrwal M, Wojarski J, et al
    NOVEL POLYANIONS INHIBITING REPLICATION OF INFLUENZA VIRUSES.
    Antimicrob Agents Chemother. 2016 Jan 4. pii: AAC.02183.
    PubMed     Text format     Abstract available


    December 2015
  18. ZHAO D, Fukuyama S, Sakai-Tagawa Y, Takashita E, et al
    C646, a novel p300/CREB-binding protein-specific inhibitor of histone acetyltransferase, attenuates influenza A virus infection.
    Antimicrob Agents Chemother. 2015 Dec 28. pii: AAC.02055.
    PubMed     Text format     Abstract available


    September 2015
  19. FAROOQUI A, Huang L, Wu S, Cai Y, et al
    Assessment of antiviral properties of Peramivir against H7N9 avian influenza virus in an experimental mouse model.
    Antimicrob Agents Chemother. 2015 Sep 14. pii: AAC.01885.
    PubMed     Text format     Abstract available


    August 2015
  20. MATSUO Y, Ishibashi T, Hollister AS, Wajima T, et al
    Population Pharmacokinetics of Peramivir in Healthy Volunteers and Influenza Patients.
    Antimicrob Agents Chemother. 2015 Aug 17. pii: AAC.00799.
    PubMed     Text format     Abstract available


    July 2015
  21. TRABOULSI H, Cloutier A, Boyapelly K, Bonin MA, et al
    The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Infection.
    Antimicrob Agents Chemother. 2015 Jul 27. pii: AAC.01098.
    PubMed     Text format     Abstract available


  22. PORTE R, Fougeron D, Munoz-Wolf N, Tabareau J, et al
    A toll-like receptor 5 agonist improves the efficacy of antibiotics in the treatment of primary and influenza-associated pneumococcal mouse infections1.
    Antimicrob Agents Chemother. 2015 Jul 20. pii: AAC.01210.
    PubMed     Text format     Abstract available


  23. TSAI AW, McNeil CF, Leeman JR, Bennett HB, et al
    A Novel Ranking System for Identifying Efficacious Anti-Influenza PB2 Inhibitors.
    Antimicrob Agents Chemother. 2015 Jul 13. pii: AAC.00781.
    PubMed     Text format     Abstract available


  24. LEU CH, Yang ML, Chung NH, Huang YJ, et al
    Kallistatin Ameliorates Influenza Virus Pathogenesis by Inhibition of Kallikrein-Related Peptidase 1-Mediated Cleavage of Viral Hemagglutinin.
    Antimicrob Agents Chemother. 2015 Jul 6. pii: AAC.00065.
    PubMed     Text format     Abstract available


    June 2015
  25. KAMAL MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, et al
    A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression.
    Antimicrob Agents Chemother. 2015 Jun 22. pii: AAC.00069.
    PubMed     Text format     Abstract available


  26. GILLMAN A, Nykvist M, Muradrasoli S, Soderstrom H, et al
    Influenza A(H7N9) Acquires Resistance Related NA-I222T Substitution when Infected Mallards are Exposed to Low Levels of Oseltamivir in Water.
    Antimicrob Agents Chemother. 2015 Jun 15. pii: AAC.00886.
    PubMed     Text format     Abstract available


  27. ITOH Y, Shichinohe S, Nakayama M, Igarashi M, et al
    Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Antimicrob Agents Chemother. 2015 Jun 8. pii: AAC.00793.
    PubMed     Text format     Abstract available


    June 2014
  28. CHOU S, Ercolani RJ, Sahoo MK, Lefterova MI, et al
    Improved Detection of Emerging Drug-resistant Mutant Cytomegalovirus Subpopulations by Deep Sequencing.
    Antimicrob Agents Chemother. 2014 Jun 2. pii: AAC.03214.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: